AI-Designed Virus Treats First Human Patient

A California startup just made medical history by treating a human patient with a virus designed entirely by artificial intelligence.

Radical Numerics announced this week that doctors administered their AI-created phage to a patient battling a deadly E. coli infection. The patient had already tried antibiotics and natural phages, but nothing worked.

Phages are special viruses that attack bacteria instead of human cells. Doctors have used them to fight infections for over a century, but finding the right phage for each patient takes weeks or months of searching through soil and water samples.

The team trained their AI model, called Omnii, to design custom phages that could target the patient's specific resistant bacteria. The AI generated new versions of a virus called T7, changing the shape of its microscopic legs so it could latch onto and kill the stubborn E. coli.

After creating 285 different designs, scientists found 16 that worked in the lab. They tested the most promising candidates for safety, then partnered with doctors to treat the patient. The FDA authorized the trial under special emergency provisions.

The company hasn't yet shared details about the patient or whether the treatment worked, citing confidentiality agreements. They plan to publish full results in a peer-reviewed journal once the trial concludes.

The Ripple Effect

This breakthrough could transform how we fight antibiotic-resistant infections, which kill over a million people worldwide each year. Instead of spending months hunting for the right natural phage, doctors could design custom viruses in days.

Dr. Marisa Azad, an infectious disease doctor in Canada working with Radical Numerics, says the technology could save patients who have run out of options. Traditional phage therapy works, but the time it takes to find matching viruses often costs lives.

The three scientists who founded Radical Numerics came from the Arc Institute, where they created an earlier AI model that successfully designed 16 working viruses from scratch. Their new model, Omnii, learns from DNA sequences, protein structures, and other biological data to create treatments tailored to individual patients.

The company is also using the same AI to design cancer vaccines and predict pandemic risks. But this first human trial of AI-designed phage therapy represents something unprecedented: medicine created by artificial intelligence to fight an infection that stumped every human-designed treatment.

While scientists urge caution until results are published, the fact that an AI could design a working virus opens doors we're only beginning to imagine.